Navigation Links
Abbott Invests Additional $20M in Isis' Subsidiary Ibis Biosciences
Date:7/1/2008

bis, and the development and commercialization of the Ibis T5000 Biosensor System and Ibis' technology. Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement, including those statements that are described as Isis' goals or projections. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, in developing and commercializing systems to identify infectious organisms that are effective and commercially attractive, and in the endeavor of building a business around such products. Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements. Although Isis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Isis. As a result, you are cautioned not to rely on these forward-looking statements. These and other risks concerning Isis' programs are described in additional detail in Isis' annual report on Form 10-K for the year ended December 31, 2007, and its quarterly report on Form 10-Q for the quarter ended March 31, 2008, which are on file with the SEC. Copies of these and other documents are available from the Company.

In this press release, unless the context requires otherwise, "Isis," "Company," "we," "our," and "us" refers to Isis Pharmaceuticals and its subsidiaries.

Isis Pharmaceuticals is a registered trademark of Isis Pharmaceuticals, Inc. Ibis Biosciences and Ibis T5000 are trademarks of Ibis Biosciences, Inc. Regulus Therapeutics is a trademark of Regulus Therapeutics LLC.


'/>"/>
SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Abbott to Present at Goldman Sachs Global Healthcare Conference
2. Abbott Launches Next-Generation StarClose(R) SE Vascular Closure System
3. Abbott Scientists Present a New Approach for Treating Attention-Deficit Hyperactivity Disorder
4. Abbott Annual Meeting Highlights Outstanding 2007 Results, International Growth and Near-Term Pipeline
5. Abbott Announces Labs Are Vital(TM) Facebook Scholarship Contest Winners
6. ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase
7. Smiths Medical to Promote and Distribute Abbotts FreeStyle Navigator Continuous Glucose Monitoring System
8. Abbott to Present at Cowen and Company Health Care Conference
9. Abbott to Present at Lehman Brothers Healthcare Conference
10. Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management
11. Isis Announces Equity Investment in Ibis Biosciences Subsidiary by Abbott; Option Acquired to Purchase Remaining Ibis Equity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... , Nov. 24, 2014   Veracyte, Inc. (Nasdaq: ... Anderson , president and chief executive officer, will present in ... Annual Healthcare Conference on Tuesday, December 2, 2014 at ... The live audio webcast and subsequent replay may ... Please connect to the website at least 15 minutes prior ...
(Date:11/24/2014)... BETHESDA, Md. , Nov. 24, 2014 /PRNewswire/ ... property development company committed to the fostering and ... regarding  Spherix v. VTech Telecommunications Ltd.,  Case No. ... , Case No. 3:13-cv-03496-M, both in the United ... Texas . ...
(Date:11/22/2014)... MA (PRWEB) November 21, 2014 ... key investors will gather on December 3rd at ... Biotech Conferences series. GeneticRx will take place at ... Medical School and will discuss the present and ... therapy, exon skipping, and gene editing—as well as ...
(Date:11/22/2014)... November 22, 2014 Respiratory therapy ... the proper management of life-like respiratory ailments using ... devices . Grand Rapids-based, Michigan Instruments Inc. developers ... two of the respiratory simulation units to the ... Grand Valley and Muskegon Community College are collaborating ...
Breaking Biology Technology:Veracyte to Present at the Piper Jaffray 26th Annual Healthcare Conference 2Markman Hearing Held as Scheduled in VTech and Uniden Cases 2Pioneering Academics and Key Industry Leaders to Discuss Rare Diseases and the Emergence of New Genetic Medicines at Genetic Rx on December 3rd 2Michigan Instruments Donates Two Respiratory Simulation Training and Test Lung (TTL) Devices to Grand Valley State University 2Michigan Instruments Donates Two Respiratory Simulation Training and Test Lung (TTL) Devices to Grand Valley State University 3
... Madison, Wis. - Using money from the Minority ... will provide loans to two minority-owned technology businesses in Madison. ... and iNOC, LLC , will receive loans to help ... a $100,000 loan for working capital to develop and market ...
... Madison, Wis. - Following a devastating legal rebuke, ... left the company he founded to pursue other business ... of the Verona-based provider of uninterruptible power supply services, ... vice president Charley Eaton was appointed president of JT ...
... Madison, Wis. - It was introduced a month ago, and ... Windows XP operating system, has been bruised by critical media ... insight from area CIOs that have tested the beta version. We ... Foundry , and Chris Luter, director of information technologies for ...
Cached Biology Technology:Wisconsin firms won't rush to adopt Microsoft Vista 2Wisconsin firms won't rush to adopt Microsoft Vista 3Wisconsin firms won't rush to adopt Microsoft Vista 4
(Date:11/4/2014)... of death at the right time might actually help ... that could help in understanding animal populations, pest control ... paper in the journal Trends in Ecology and ... conclude that the kind of positive population effect an ... mortality, depends on the size and developmental stage of ...
(Date:11/4/2014)... of Madagascar,s 101 species of lemurs are threatened with ... rainforests they call home. A new study by Rice ... on rainforest tree populations, which raises concerns about the ... rich biodiversity. , A large proportion of trees in ... in turn disperse the seeds of their fruit trees ...
(Date:11/3/2014)... Australia report that low birth weight and preterm birth ... replacements in adulthood. Findings published in the American College ... , indicate that low birth weight and pre-term babies ... to OA as adults. , According to the ... are diagnosed with clinical OA. Symptoms of OA range ...
Breaking Biology News(10 mins):When less is more: Death in moderation boosts population density in nature 2Gardeners of Madagascar rainforest at risk 2Gardeners of Madagascar rainforest at risk 3Preterm, low birth-weight babies may need new hips in adulthood 2
... researcher, please contact the Communications and External Relations staff member identified ... and its research and development activities, please refer to one of ... comment, you can send it to news@ornl.gov . ... The software-writing mistakes known as "bugs" can be a pain ...
... (July 29, 2010) Polymer strands wriggle their way through ... there and do their jobs. New theoretical research by Rice ... That,s a good thing to know for scientists studying ... which count as polymers -- or those who are developing ...
... Salmonella that affects its virulence and its susceptibility to ... unheard of manner. This allows Salmonella to selectively ... conditions. Although the mechanism had not been recognized ... similar mechanism in all five kingdoms of life animals, ...
Cached Biology News:Story tips from the Department of Energy's Oak Ridge National Laboratory, August 2010 2Story tips from the Department of Energy's Oak Ridge National Laboratory, August 2010 3Story tips from the Department of Energy's Oak Ridge National Laboratory, August 2010 4Polymer passage takes time 2Mechanism uncovered behind Salmonella virulence and drug susceptibility 2Mechanism uncovered behind Salmonella virulence and drug susceptibility 3Mechanism uncovered behind Salmonella virulence and drug susceptibility 4
Rat Aortic Endothelial Cells (RAOEC) (>500,000 cells)...
... The Brownlee Precision Model 440 incorporates ... circuitry in a friendly easy-to-use instrument. Each ... amplifier, an 8-pole Bessel lowpass filter, a ... output offset controls. A control knob sets ...
... licensed, high throughput, water bath thermal cycler capable ... microplates. This equates to 9,216 reactions per run ... arm rapidly transfers a basket of plates between ... that are considerably faster than those of peltier ...
... Model 410 is a four-channel general purpose laboratory ... signals from sources which may have a large ... consists of a high gain/low noise amplifier, an ... an output offset control. A control knob sets ...
Biology Products: